Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Jiang, Guosong ^a   Zheng, Liduan ^a   Pu, Jiarui ^a   Mei, Hong ^a   Zhao, Jun ^a   Huang, Kai ^a   Zeng, Fuqing ^a   Tong, Qiangsong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; ARGONAUTE 2 PROTEIN; BISULFITE; EARLY GROWTH RESPONSE FACTOR 1; HEPARANASE; RNA POLYMERASE II; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR IIB; TRANSCRIPTION FACTOR SP1; ARGONAUTE PROTEIN; BETA GLUCURONIDASE; EIF2C1 PROTEIN, HUMAN; EIF2C2 PROTEIN, HUMAN; HISTONE; INITIATION FACTOR;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; GENETIC MARKER; GENETIC TRANSFECTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN TARGETING; RNA BINDING; RNA INTERFERENCE; RNA METHYLATION; RNA TRANSCRIPTION; STOMACH CANCER; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION; ACETYLATION; CELL ADHESION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ACETYLATION; ARGONAUTE PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EUKARYOTIC INITIATION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HISTONES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84857377246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031379     Document Type: Article

References (51)

1. Ilan N, Elkin M, Vlodavsky I, (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38: 2018-2039.
2. Nakajima M, Irimura T, Di Ferrante N, Nicolson GL, (1984) Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259: 2283-2290.
3. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, et al. (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J 15: 1661-1663.
4. Vlodavsky I, Friedmann Y, (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108: 341-347.
5. Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, et al. (2005) Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 11: 1028-1036.
6. Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, et al. (2005) Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 24: 6765-6772.
7. Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, et al. (2002) Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol 15: 593-598.
8. Wang Z, Xu H, Jiang L, Zhou X, Lu C, et al. (2004) Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod Pathol 18: 205-211.
9. Izquierdo M, (2004) Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 12: 217-227.
10. Weinberg MS, Villeneuve LM, Ehsani A, Amarzguioui M, Aagaard L, et al. (2006) The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12: 256-262.
11. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV, (2009) Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 37: 2984-2995.
12. Turner AM, De La Cruz J, Morris KV, (2009) Mobilization-competent lentiviral vector- mediated sustained transcriptional modulation of HIV-1 Expression. Mol Ther 17: 360-368.
13. Castanotto D, Tommasi S, Li M, Li H, Yanow S, et al. (2005) Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther 12: 179-183.
14. Murayama A, Sakura K, Nakama M, Yasuzawa-Tanaka K, Fujita E, et al. (2006) A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25: 1081-1092.
15. Alló M, Buggiano V, Fededa JP, Petrillo E, Schor I, et al. (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol 16: 717-724.
16. Down TA, Hubbard TJ, (2002) Computational detection and location of transcription start sites in mammalian genomic DNA. Genome Res 12: 458-461.
17. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5: 793-802.
18. Jiang P, Kumar A, Parrillo JE, Dempsey LA, Platt JL, et al. (2002) Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem 277: 8989-8998.
19. Dong J, Kukula AK, Toyoshima M, Nakajima M, (2000) Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 253: 171-178.
20. Toyoshima M, Nakajima M, (1999) Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274: 24153-24160.
21. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, et al. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5: 803-809.
22. Li B, Carey M, Workman JL, (2007) The role of chromatin during transcription. Cell 128: 707-719.
23. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, et al. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-750.
24. Kim DH, Rossi JJ, (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet 8: 173-184.
25. Tolia NH, Joshua-Tor L, (2007) Slicer and the Argonautes. Nat Chem Biol 3: 36-43.
26. Kavi H, Birchler J, (2009) Interaction of RNA polymerase II and the small RNA machinery affects heterochromatic silencing in Drosophila. Epigenetics Chromatin 2: 15.
27. Chen BS, Hampsey M, (2004) Functional Interaction between TFIIB and the Rpb2 Subunit of RNA Polymerase II: Implications for the Mechanism of Transcription Initiation. Mol Cell Biol 24: 3983-3991.
28. Chen HT, Hahn S, (2004) Mapping the location of TFIIB within the RNA polymerase II transcription preinitiation complex: a model for the structure of the PIC. Cell 119: 169-180.
29. Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, et al. (2009) Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res 105: 604-609.
30. Yamagishi M, Ishida T, Miyake A, Cooper DA, Kelleher AD, et al. (2009) Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription. Microbes Infect 11: 500-508.
31. Matzke MA, Primig M, Trnovsky J, Matzke AJ, (1989) Reversible methylation and inactivation of marker genes in sequentially transformed tobacco plants. EMBO J 8: 643-649.
32. Kim DH, Villeneuve LM, Morris KV, Rossi JJ, (2006) Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 13: 793-797.
33. Suzuki K, Kelleher AD, (2009) Transcriptional regulation by promoter targeted RNAs. Curr Top Med Chem 9: 1079-1087.
34. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA, Hulett MD, (2003) Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem 278: 50377-50385.
35. Haraguchi T, Mizutani T, Yamamichi N, Ito T, Minoguchi S, et al. (2007) SiRNAs do not induce RNA-dependent transcriptional silencing of retrovirus in human cells. FEBS Lett 581: 4949-4954.
36. Janowski BA, Huffman KE, Schwartz JC, Ram R, Hardy D, et al. (2005) Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat Chem Biol 1: 216-222.
37. Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, et al. (2006) Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 13: 787-792.
38. Schubert S, Grünweller A, Erdmann VA, Kurreck J, (2005) Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol 348: 883-893.
39. Han J, Kim D, Morris KV, (2007) Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci USA 104: 12422-12427.
40. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV, (2009) Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 28: 1708-1719.
41. Janowski BA, Hu J, Corey DR, (2006) Silencing gene expression by targeting chromosomal DNA with antigene peptide nucleic acids and duplex RNAs. Nat Protocols 1: 436-443.
42. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, et al. (2010) ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17: 17-23.
43. Komatsu N, Waki M, Sue M, Tokuda C, Kasaoka T, et al. (2008) Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies. J Immunol Methods 331: 82-93.
44. Cangemi R, Mensah A, Albertini V, Jain A, Mello-Grand M, et al. (2007) Reduced expression and tumor suppressor function of the ETS transcription factor ESE-3 in prostate cancer. Oncogene 27: 2877-2885.
45. Pulukuri SMK, Rao JS, (2007) Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis. Cancer Res 67: 6637-6646.
46. Zheng L, Jiang G, Mei H, Pu J, Dong J, et al. (2010) Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer 10: 33.
47. Zhang MX, Ou H, Shen YH, Wang J, Coselli J, et al. (2005) Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 102: 16967-16972.
48. Huang D, Yang C, Wang Y, Liao Y, Huang K, (2009) PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts. Cardiovasc Res 81: 98-107.
49. Sako A, Kitayama J, Koyama H, Ueno H, Uchida H, et al. (2004) Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Cancer Res 64: 3624-3628.
50. Zhang ZH, Chen Y, Zhao HJ, Xie CY, Ding J, et al. (2007) Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. Cancer Biol Ther 6: 587-595.
51. Zheng L, Pu J, Jiang G, Weng M, He J, et al. (2010) Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol Int 60: 268-277.